中国生物制药(01177)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01177 中国生物制药

已收盘 02-10 16:09:14

6.790

+0.190

+2.88%

最高6.970	最低6.600	成交量7,987万
今开6.600	昨收6.600	日振幅5.61%
总市值1,274亿	流通市值1,274亿	总股本187.61亿
成交额5.45亿	换手率0.43%	流通股本187.61亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01177","market":"HK","secType":"STK","nameCN":"中国生物制药","latestPrice":6.79,"timestamp":1770710954003,"preClose":6.6,"halted":0,"volume":79870307,"delay":0,"changeRate":0.02878787878787885,"floatShares":18761000000,"shares":18761000000,"eps":0.2164101748413021,"marketStatus":"已收盘","change":0.19,"latestTime":"02-10 16:09:14","open":6.6,"high":6.97,"low":6.6,"amount":544955289,"amplitude":0.056061,"askPrice":6.79,"askSize":340000,"bidPrice":6.78,"bidSize":594000,"shortable":3,"etf":0,"ttmEps":0.24187625050814593,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770773400000},"marketStatusCode":5,"adr":0,"listingDate":1070812800000,"exchange":"SEHK","adjPreClose":6.6,"dividendRate":0.013506,"openAndCloseTimeList":[[1770687000000,1770696000000],[1770699600000,1770710400000]],"volumeRatio":1.278325,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"SBO.HK","impliedVol":0.3485,"impliedVolPercentile":0.0884},"requestUrl":"/m/hq/s/01177","defaultTab":"news","newsList":[{"id":"2610641826","title":"正大天晴（中国生物制药）深度调研报告：创新转型的跨越与全球化征途的破局","url":"https://stock-news.laohu8.com/highlight/detail?id=2610641826","media":"Ofweek维科网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610641826?lang=zh_cn&edition=full","pubTime":"2026-02-10 16:31","pubTimestamp":1770712268,"startTime":"0","endTime":"0","summary":"正大天晴作为中生制药最为核心的附属公司，贡献了集团绝大部分的营收与利润，其实质运营状况直接决定了上市主体的二级市场表现与长期价值。这种“引进来”与“走出去”的双向流动，标志着正大天晴已具备参与全球医药创新产业链分工的能力。2024年，肿瘤药物销售额约107.3亿元，占总营收比重达37.2%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210163542a6e9af5a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210163542a6e9af5a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1521","HK0000165453.HKD","IE00BZ08YR35.GBP","01177","BK1191","BK1589","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","BK1515"],"gpt_icon":0},{"id":"2610969486","title":"创新药概念震荡反弹 高增长潜力概念股出炉","url":"https://stock-news.laohu8.com/highlight/detail?id=2610969486","media":"腾讯自选股综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610969486?lang=zh_cn&edition=full","pubTime":"2026-02-10 11:17","pubTimestamp":1770693474,"startTime":"0","endTime":"0","summary":"创新药概念盘中震荡反弹，广生堂涨超10%，此前万邦德涨停，尖峰集团、信立泰、北陆药业、荣昌生物、首药控股等多股涨超5%。华源证券指出，经历短期波动消化后，创新药板块已显现企稳回暖迹象。整体上，国金证券认为创新药前期回调较为充分，向上产业趋势明确，催化近期密集，继续看好板块投资机会。从未来增长潜力来看，多股获机构预测2026年净利增速有望翻倍。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021010545497a590eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021010545497a590eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","01276","03692","01548","00013","01177","BK1574","BK1583","01952","01801","02228","02269","06160","BK1161","01877","06978","02196"],"gpt_icon":0},{"id":"2610699154","title":"中国生物制药(01177)升5% TQB2102 III期临床完成入组 此前Ib期ASCO数据良好","url":"https://stock-news.laohu8.com/highlight/detail?id=2610699154","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610699154?lang=zh_cn&edition=full","pubTime":"2026-02-10 10:52","pubTimestamp":1770691959,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中国生物制药(01177)短线拉高，截止发稿， 升5.15%，报6.94港元，成交额1.94亿港元。公司公告公布，集团自主研发的国家1类创新药TQB2102“HER2双抗ADC”正在开展一项“评价注射用TQB2102对比研究者选择的化疗在HER2低表达复发╱转移性乳腺癌中有效性和安全性的随机、开放、平行对照的III期临床试验(TQB2102-III-01)”，近期已完成全部受试者入组。在2025年美国临床肿瘤学会(ASCO)年会上，集团公布了TQB2102用于HER2低表达晚期乳腺癌的 Ib期临床研究结果，显示出良好的疗效与安全性。","market":"hk","thumbnail":"https://static.szfiu.com/news/20241108/ODBhOTU0MzI3NjMwOTM5MjE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ODBhOTU0MzI3NjMwOTM5MjE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1974849","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1521","IE00BZ08YT58.USD","01177","IE00BZ08YS42.EUR","BK1589","BK4134","HK0000165453.HKD","BK1191","IE00BZ08YR35.GBP","BK1515","III"],"gpt_icon":0},{"id":"1181610865","title":"异动解读 | 乳腺癌药物III期临床试验完成受试者入组，中国生物制药盘中大涨5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1181610865","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1181610865?lang=zh_cn&edition=full","pubTime":"2026-02-10 10:41","pubTimestamp":1770691267,"startTime":"0","endTime":"0","summary":"中国生物制药今日盘中大涨5%，引起了市场的广泛关注。消息面上，公司自主研发的国家1类创新药TQB2102“HER2双抗ADC”用于治疗HER2低表达复发/转移性乳腺癌的III期临床试验，近期已完成全部受试者入组。TQB2102是公司自主研发的新一代抗体偶联药物，采用了双表位靶向设计、可裂解连接子及优化的药物抗体比等核心技术，旨在为HER2低表达乳腺癌患者提供新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["01177"],"gpt_icon":0},{"id":"2610615985","title":"中国生物制药盘中异动 大幅拉升3.03%报6.800港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610615985","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610615985?lang=zh_cn&edition=full","pubTime":"2026-02-10 09:48","pubTimestamp":1770688118,"startTime":"0","endTime":"0","summary":"2026年02月10日早盘09时48分，中国生物制药股票出现异动，股价急速上涨3.03%。截至发稿，该股报6.800港元/股，成交量614.025万股，换手率0.03%，振幅3.03%。资金方面，该股资金流入2579.63万港元，流出1043.47万港元。中国生物制药股票所在的药品行业中，整体涨幅为0.55%。其相关个股中，英硅智能、劲方医药-B、德琪医药-B涨幅较大，振幅较大的相关个股有英硅智能、宝济药业-B、劲方医药-B，振幅分别为8.41%、7.25%、5.76%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210094838954081f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210094838954081f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","IE00BZ08YT58.USD","BK1589","BK1521","IE00BZ08YS42.EUR","01177","BK1191","IE00BZ08YR35.GBP","HK0000165453.HKD"],"gpt_icon":0},{"id":"2610661036","title":"中国生物制药(01177)：TQB2102“HER2双抗ADC”HER2低表达乳腺癌III期临床试验完成受试者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2610661036","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610661036?lang=zh_cn&edition=full","pubTime":"2026-02-10 06:16","pubTimestamp":1770675411,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国生物制药 发布公告，集团自主研发的国家1类创新药TQB2102“HER2双抗ADC”正在开展一项“评价注射用TQB2102对比研究者选择的化疗在HER2低表达复发╱转移性乳腺癌中有效性和安全性的随机、开放、平行对照的III期临床试验”，近期已完成全部受试者入组。以上核心技术的结合，突破了传统HER2单抗及单靶点ADC的局限，使TQB2102在HER2低表达肿瘤治疗中展现出显著潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1403406.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4080","BK1521","HK0000165453.HKD","IE00BZ08YR35.GBP","01177","BK4134","BK1191","BK1589","BK4231","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","III","ADC","BK1515"],"gpt_icon":0},{"id":"2610615938","title":"每日卖空追踪 | 中国生物制药 02月09日卖空量成交885.6万股，卖空比例为17.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610615938","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610615938?lang=zh_cn&edition=full","pubTime":"2026-02-09 16:30","pubTimestamp":1770625819,"startTime":"0","endTime":"0","summary":"中国生物制药北京时间02月09日，涨1.85%，卖空量成交885.6万股，较上一交易日减少52.02%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209163601a6e54dae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209163601a6e54dae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","IE00BZ08YT58.USD","BK1589","BK1191","BK1521","IE00BZ08YS42.EUR","01177","IE00BZ08YR35.GBP","HK0000165453.HKD"],"gpt_icon":0},{"id":"2610681304","title":"中国生物制药盘中异动 股价大涨3.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610681304","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610681304?lang=zh_cn&edition=full","pubTime":"2026-02-09 09:33","pubTimestamp":1770600813,"startTime":"0","endTime":"0","summary":"2026年02月09日早盘09时33分，中国生物制药股票出现异动，股价大幅上涨3.09%。截至发稿，该股报6.680港元/股，成交量485.7万股，换手率0.03%，振幅2.47%。资金方面，该股资金流入2019.35万港元，流出842.054万港元。中国生物制药股票所在的药品行业中，整体涨幅为0.27%。其相关个股中，信达生物、中智药业、德琪医药-B涨幅较大，振幅较大的相关个股有德琪医药-B、中智药业、信达生物，振幅分别为4.49%、4.17%、3.90%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020909333397a56337&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020909333397a56337&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","IE00BZ08YR35.GBP","BK1515","01177","HK0000165453.HKD","BK1589","BK1521","IE00BZ08YS42.EUR","IE00BZ08YT58.USD"],"gpt_icon":0},{"id":"2610503880","title":"中国生物制药(01177)：维特柯妥拜单抗“CLDN18.2 ADC”III期临床试验完成受试者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2610503880","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610503880?lang=zh_cn&edition=full","pubTime":"2026-02-09 06:15","pubTimestamp":1770588951,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国生物制药 发布公告，集团全资附属公司礼新医药科技(上海)有限公司自主研发的国家1类创新药维特柯妥拜单抗“CLDN18.2 ADC”正在开展用于治疗三线及以上CLDN18.2阳性的局部晚期或转移性胃及胃食管交界部腺癌的III期注册临床试验，已顺利完成患者入组。其中，LM302是全球首款完成注册III期临床试验入组的CLDN18.2 ADC药物。该研究表明，LM302联合治疗方案在CLDN18.2阳性患者中展现出显著的抗肿瘤活性和可管理的安全性特征。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1402910.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4080","BK4134","01177","BK4231","HK0000165453.HKD","BK1515","III","IE00BZ08YT58.USD","BK1191","BK1589","BK1521","IE00BZ08YS42.EUR","ADC","IE00BZ08YR35.GBP"],"gpt_icon":0},{"id":"2609730592","title":"每日卖空追踪 | 中国生物制药 02月06日卖空量成交1041.5万股，卖空比例为18.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609730592","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609730592?lang=zh_cn&edition=full","pubTime":"2026-02-06 16:30","pubTimestamp":1770366620,"startTime":"0","endTime":"0","summary":"中国生物制药北京时间02月06日，涨0.78%，卖空量成交1041.5万股，较上一交易日减少56.42%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206163252a483ccf4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206163252a483ccf4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01177","BK1191","BK1515","HK0000165453.HKD","BK1521","BK1589","IE00BZ08YR35.GBP","IE00BZ08YS42.EUR","IE00BZ08YT58.USD"],"gpt_icon":0},{"id":"2609020536","title":"【券商聚焦】中泰国际：政策继续支持高品质创新药与高端医疗器械","url":"https://stock-news.laohu8.com/highlight/detail?id=2609020536","media":"金吾财讯","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609020536?lang=zh_cn&edition=full","pubTime":"2026-02-06 08:40","pubTimestamp":1770338454,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中泰国际发布医药行业2月投资策略，生医疗保健指数1月上涨8.6%，跑赢恒生指数1.7个百分点，主因：1)CXO板块多家企业发布盈喜预告，推动股价上涨。3)国家医保局发布政策支持高品质手术机器人获溢价，医疗器械板块中相关个股上涨。该机构指，国家药监局继续支持高品质创新药发展。中国生物制药本身在肝病、自免、呼吸、肿瘤等领域已有丰富布局，本次通过收购将夯实心血管领域的竞争力。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1974664","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06978","LU0417516738.SGD","LU2125910500.SGD","HK0000165453.HKD","LU0327786744.USD","BK1191","LU0326950275.SGD","LU2039709279.SGD","LU0823426480.USD","09997","IE00BZ08YT58.USD","LU0348735423.USD","LU0708995583.HKD","LU0348825331.USD","02269","09996","03696","LU0307460666.USD","SG9999002562.SGD","02359","IE00BZ08YS42.EUR","LU0516423091.SGD","LU0181495838.USD","LU0359201612.USD","LU0456827905.SGD","LU0516422366.SGD","LU0516422952.EUR","LU2045819591.USD","LU0572944931.SGD","LU0823426308.USD","LU0052750758.USD","159992","159883","BK1576","BK1515","01177","LU0516422440.USD","SG9999002463.SGD","LU1242518857.USD","LU0456846285.SGD","IE00B0JY6N72.USD","LU0039217434.USD","LU0140636845.USD","BK1574","LU0043850808.USD","LU0359202008.SGD","BK1610","LU0516423174.USD","LU0320764599.SGD","BK1222"],"gpt_icon":0},{"id":"2609559276","title":"安罗替尼联合治疗非小细胞肺癌创新方案荣登《Nature》子刊 助力患者术前实现肿瘤深度缓解","url":"https://stock-news.laohu8.com/highlight/detail?id=2609559276","media":"正大制药订阅号","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609559276?lang=zh_cn&edition=full","pubTime":"2026-02-06 07:00","pubTimestamp":1770332424,"startTime":"0","endTime":"0","summary":"近日，中国生物制药1类新药安罗替尼联合派安普利单抗联合化疗用于IIB-IIIB期非小细胞肺癌患者围术期治疗的三臂前瞻性临床试验研究，在线发表于《Nature》子刊《Signal Transduction and Targeted Therapy》。提示派安普利±安罗替尼±化疗方案均可为患者在术前实现肿瘤的深度缓解，尤其是去化疗组，使更多患者有机会接受手术切除治疗。ALTER-L043为非小细胞肺癌围手术期治疗模式进行了有重大意义的探索。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206070433954009f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206070433954009f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000165453.HKD","BK1589","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","BK1191","BK1521","IE00BZ08YR35.GBP","01177","BK1515"],"gpt_icon":0},{"id":"2608680983","title":"每日卖空追踪 | 中国生物制药 02月04日卖空量成交683.3万股，卖空比例为17.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608680983","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608680983?lang=zh_cn&edition=full","pubTime":"2026-02-04 16:30","pubTimestamp":1770193819,"startTime":"0","endTime":"0","summary":"中国生物制药北京时间02月04日，涨0.79%，卖空量成交683.3万股，较上一交易日减少74.08%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204163357a47b0c4a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204163357a47b0c4a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BZ08YS42.EUR","IE00BZ08YT58.USD","BK1191","BK1589","IE00BZ08YR35.GBP","BK1521","BK1515","01177","HK0000165453.HKD"],"gpt_icon":0},{"id":"2609390397","title":"中国生物制药02月04日获主力加仓1391.5万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2609390397","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609390397?lang=zh_cn&edition=full","pubTime":"2026-02-04 16:16","pubTimestamp":1770192967,"startTime":"0","endTime":"0","summary":"02月04日, 中国生物制药股价涨0.79%，报收6.39元，成交金额2.5亿元，换手率0.21%，振幅4.42%，量比0.46。中国生物制药今日主力资金净流入1391.5万元，上一交易日主力净流入5809.3万元。该股近5个交易日下跌5.42%，主力资金累计净流出3626.5万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出2.8亿元，其中净流出天数为16日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204162434a47b0289&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204162434a47b0289&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BZ08YS42.EUR","HK0000165453.HKD","IE00BZ08YT58.USD","BK1589","BK1191","01177","IE00BZ08YR35.GBP","BK1515","BK1521"],"gpt_icon":0},{"id":"2608928608","title":"每日卖空追踪 | 中国生物制药 02月02日卖空量成交853万股，卖空比例为10.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608928608","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608928608?lang=zh_cn&edition=full","pubTime":"2026-02-02 16:30","pubTimestamp":1770021019,"startTime":"0","endTime":"0","summary":"中国生物制药北京时间02月02日，跌5.27%，卖空量成交853万股，较上一交易日减少68.33%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202163310a4728a8e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202163310a4728a8e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1589","IE00BZ08YR35.GBP","IE00BZ08YT58.USD","BK1521","BK1191","IE00BZ08YS42.EUR","HK0000165453.HKD","01177","BK1515"],"gpt_icon":0},{"id":"2608892865","title":"中国生物制药盘中异动 早盘大幅下跌3.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608892865","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608892865?lang=zh_cn&edition=full","pubTime":"2026-02-02 09:47","pubTimestamp":1769996878,"startTime":"0","endTime":"0","summary":"2026年02月02日早盘09时47分，中国生物制药股票出现波动，股价急速跳水3.01%。截至发稿，该股报6.440港元/股，成交量966.6万股，换手率0.05%，振幅3.01%。资金方面，该股资金流入2138.22万港元，流出3651.4万港元。中国生物制药股票所在的药品行业中，整体跌幅为0.78%。其相关个股中，励晶太平洋、康哲药业、石药集团涨幅较大，振幅较大的相关个股有英硅智能、康哲药业、石药集团，振幅分别为5.72%、4.99%、4.79%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202094758a6c81474&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202094758a6c81474&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000165453.HKD","IE00BZ08YR35.GBP","BK1191","BK1515","IE00BZ08YT58.USD","BK1521","01177","IE00BZ08YS42.EUR","BK1589"],"gpt_icon":0},{"id":"2607306094","title":"中国生物制药盘中异动 早盘大幅跳水3.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607306094","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607306094?lang=zh_cn&edition=full","pubTime":"2026-01-30 10:20","pubTimestamp":1769739641,"startTime":"0","endTime":"0","summary":"2026年01月30日早盘10时20分，中国生物制药股票出现波动，股价快速下挫3.06%。截至发稿，该股报6.660港元/股，成交量2323.01万股，换手率0.12%，振幅3.35%。中国生物制药股票所在的药品行业中，整体跌幅为0.27%。其相关个股中，三爱健康集团、海王英特龙、康臣药业涨幅较大，振幅较大的相关个股有石药集团、劲方医药-B、英硅智能，振幅分别为14.97%、6.32%、5.88%。中国生物制药公司简介：本集团业务覆盖医药各种研发平台、智能化生产和强大销售体系全产业链。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130102041a466fb9e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130102041a466fb9e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01177","HK0000165453.HKD","BK1515","IE00BZ08YT58.USD","BK1589","BK1191","BK1521","IE00BZ08YS42.EUR","IE00BZ08YR35.GBP"],"gpt_icon":0},{"id":"2607065279","title":"【券商聚焦】交银国际维持中国生物制药(01177)买入评级 指其业绩增长动力充足","url":"https://stock-news.laohu8.com/highlight/detail?id=2607065279","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607065279?lang=zh_cn&edition=full","pubTime":"2026-01-30 09:22","pubTimestamp":1769736140,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际研报指，中国生物制药 2026-27年业绩增长动力充足：该机构预计2026-27年产品收入每年增长10-11%，主要来自：1）安罗替尼医保未降价、且覆盖范围拓展至一线软组织肉瘤，2026年内联合PD-L1的一线肺鳞癌、III期NSCLC巩固治疗等大适应症有望获批。该机构指，2026年催化剂来自PoC/早期数据密集读出及BD出海潜力：1）肿瘤：礼新CCR8 单抗和CLDN18.2 ADC 的 II 期，及 PD-1/TGF-β 融合蛋白的PDAC II 期数据。2026年还可重点关注自研管线及礼新、赫吉亚的诸多BD出海机会。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250109/MjZhZmU5OWE5M2M5YjFiNzE1NDI2Mjg5NzQxNQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MjZhZmU5OWE5M2M5YjFiNzE1NDI2Mjg5NzQxNQ==.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1974251","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01177"],"gpt_icon":0},{"id":"2607224032","title":"每日卖空追踪 | 中国生物制药 01月29日卖空量成交491.9万股，卖空比例为7.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607224032","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607224032?lang=zh_cn&edition=full","pubTime":"2026-01-29 16:30","pubTimestamp":1769675420,"startTime":"0","endTime":"0","summary":"中国生物制药北京时间01月29日，涨0.59%，卖空量成交491.9万股，较上一交易日减少68.26%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129163757a463e84c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129163757a463e84c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1589","HK0000165453.HKD","IE00BZ08YT58.USD","BK1515","IE00BZ08YS42.EUR","IE00BZ08YR35.GBP","01177","BK1191","BK1521"],"gpt_icon":0},{"id":"2607572853","title":"每日卖空追踪 | 中国生物制药 01月28日卖空量成交988.4万股，卖空比例为10.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607572853","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607572853?lang=zh_cn&edition=full","pubTime":"2026-01-28 16:30","pubTimestamp":1769589019,"startTime":"0","endTime":"0","summary":"中国生物制药北京时间01月28日，涨2.4%，卖空量成交988.4万股，较上一交易日增加27.03%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128164505a45f8921&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128164505a45f8921&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BZ08YT58.USD","IE00BZ08YS42.EUR","IE00BZ08YR35.GBP","01177","BK1515","BK1191","BK1589","HK0000165453.HKD","BK1521"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sinobiopharm.com","stockEarnings":[{"period":"1week","weight":0.0493},{"period":"1month","weight":-0.0337},{"period":"3month","weight":-0.0393},{"period":"6month","weight":-0.1384},{"period":"1year","weight":1.2533},{"period":"ytd","weight":0.068}],"compareEarnings":[{"period":"1week","weight":0.0094},{"period":"1month","weight":0.0303},{"period":"3month","weight":0.0124},{"period":"6month","weight":0.0552},{"period":"1year","weight":0.2789},{"period":"ytd","weight":0.0545}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"中国生物制药有限公司是一家主要从事制药业务的投资控股公司。该公司通过三个分部运营。中药现代制剂及西药分部主要从事生产、销售及配销中药现代制剂及西药产品业务。投资分部主要从事长期投资业务。其他分部主要从事相关医疗及医院业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.434783,"avgChangeRate":0.008254},{"month":2,"riseRate":0.652174,"avgChangeRate":0.060288},{"month":3,"riseRate":0.590909,"avgChangeRate":0.048254},{"month":4,"riseRate":0.5,"avgChangeRate":0.025891},{"month":5,"riseRate":0.727273,"avgChangeRate":0.043347},{"month":6,"riseRate":0.363636,"avgChangeRate":0.00957},{"month":7,"riseRate":0.636364,"avgChangeRate":0.047691},{"month":8,"riseRate":0.409091,"avgChangeRate":-0.010062},{"month":9,"riseRate":0.409091,"avgChangeRate":-0.015174},{"month":10,"riseRate":0.545455,"avgChangeRate":0.025184},{"month":11,"riseRate":0.5,"avgChangeRate":0.066781},{"month":12,"riseRate":0.409091,"avgChangeRate":-0.01175}],"exchange":"SEHK","name":"中国生物制药","nameEN":"SINO BIOPHARM"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"中国生物制药(01177)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供中国生物制药(01177)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"中国生物制药,01177,中国生物制药股票,中国生物制药股票老虎,中国生物制药股票老虎国际,中国生物制药行情,中国生物制药股票行情,中国生物制药股价,中国生物制药股市,中国生物制药股票价格,中国生物制药股票交易,中国生物制药股票购买,中国生物制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"中国生物制药(01177)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供中国生物制药(01177)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}